Smith & Nephew plc (NYSE:SNN) Short Interest Up 28.4% in November

Smith & Nephew plc (NYSE:SNN) saw a large increase in short interest in November. As of November 15th, there was short interest totalling 3,120,000 shares, an increase of 28.4% from the October 31st total of 2,430,000 shares. Currently, 0.7% of the shares of the stock are sold short. Based on an average daily volume of 799,500 shares, the short-interest ratio is currently 3.9 days.

Smith & Nephew Trading Up 0.3 %

NYSE SNN opened at $25.79 on Friday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51. Smith & Nephew has a 1 year low of $23.65 and a 1 year high of $31.72. The stock’s 50-day moving average price is $27.58 and its two-hundred day moving average price is $27.87.

Institutional Investors Weigh In On Smith & Nephew

A number of large investors have recently made changes to their positions in SNN. Brandes Investment Partners LP grew its holdings in shares of Smith & Nephew by 20.5% during the second quarter. Brandes Investment Partners LP now owns 1,373,051 shares of the medical equipment provider’s stock valued at $34,002,000 after buying an additional 233,293 shares in the last quarter. River Road Asset Management LLC acquired a new stake in Smith & Nephew during the 3rd quarter worth about $38,588,000. Bank of Montreal Can grew its stake in Smith & Nephew by 355.8% during the 2nd quarter. Bank of Montreal Can now owns 1,235,916 shares of the medical equipment provider’s stock valued at $31,059,000 after acquiring an additional 964,762 shares in the last quarter. Hsbc Holdings PLC increased its holdings in shares of Smith & Nephew by 18.9% in the 2nd quarter. Hsbc Holdings PLC now owns 548,691 shares of the medical equipment provider’s stock valued at $13,607,000 after purchasing an additional 87,360 shares during the period. Finally, Dimensional Fund Advisors LP lifted its position in shares of Smith & Nephew by 58.2% in the second quarter. Dimensional Fund Advisors LP now owns 524,602 shares of the medical equipment provider’s stock worth $12,995,000 after purchasing an additional 193,046 shares in the last quarter. Institutional investors and hedge funds own 25.64% of the company’s stock.

Analyst Ratings Changes

SNN has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft downgraded shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday, November 1st. StockNews.com downgraded Smith & Nephew from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, November 12th. Finally, Berenberg Bank cut Smith & Nephew from a “buy” rating to a “hold” rating in a report on Wednesday, November 6th.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.